European Union officials rescued more than 600 migrants from boats in the Mediterranean and recovered the bodies of three people during rescue operations near Sicily's Catania. Rough Cut (no reporter narration).
SAN DIEGO, April 23, 2024--Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on April 24
MILWAUKEE, April 23, 2024--Rockwell Automation, Inc. (NYSE: ROK) is scheduled to report its second quarter fiscal 2024 results on Tuesday, May 7, before the market opens. The release will be posted on the Rockwell Investor Relations website at www.rockwellautomation.com/en-us/investors.html.
The boutique startup specializing in AI security and governance unveils its security plugin for AI Chatbots, AI Agents and LLM’sFrisco, TX, April 23, 2024 (GLOBE NEWSWIRE) -- Arhasi, a boutique startup leading in AI security, governance, and compliance, introduced today its groundbreaking Confidentiality Concierge service. Arhasi is offering two versions of this service: a free-to-use playground for democratized use, and a dedicated enterprise solution that provides an advanced, curated level of
New Study Shows that CBD, Hemp-Derived THC and Cannabinol (CBN) Work Synergistically to Improve Sleep CBDistillery’s shhh+ Distilled THC+CBN Deep Sleep Gummies CBDistillery’s shhh+ Distilled THC+CBN Deep Sleep Gummies help users to achieve better-quality rest, fall back to sleep during the night and wake up feeling refreshed. DENVER, April 23, 2024 (GLOBE NEWSWIRE) -- Balanced Health Botanicals’ (a wholly-owned subsidiary of Village Farms International (NASDAQ: VFF)) CBDistillery™ one of the bes
Software-as-a-Service (SaaS) designed to operate on NVIDIA AI computing for drones and roboticsOS3 enables unparalleled operational situational awareness, automated response, and mediation capabilities to neutralize malfunctions and threats across the operations stack from the drone and robot to the cloudMaximizes resilience to ensure financial performance of fleets for service providers, operators, and manufacturers Shoham, Israel, April 23, 2024 (GLOBE NEWSWIRE) -- Mobilicom Limited (Nasdaq: M
AUSTIN, Texas, April 23, 2024--Zilliant, the leader in pricing lifecycle management, today announced an updated edition of "Stop Racing In A Blindfold!: Big Data + Pricing Science Drive Bigger Profits," by Jim Vaughn, the company’s global head of pricing advisory services.
DRESDEN, Germany & LEXINGTON, Mass., April 23, 2024--Seamless Therapeutics today announced the appointments of Albert Seymour, Ph.D., as its new President and Chief Executive Officer and Adam Rosenberg as Independent Chairman of the company’s Board of Directors. Both bring longstanding track records of successfully leading trailblazing biotechnology companies with an emphasis on gene editing and novel technologies. In addition, their combined experience will be instrumental in establishing Seaml
SASKATOON, Saskatchewan, April 23, 2024--ZYUS Life Sciences Corp receives U.S. Patent No. 11,963,943, entitled FORMULATION FOR PAIN MANAGEMENT.
ANOKA, Minn., April 23, 2024--Revelyst, a collective of world-class maker brands that design and manufacture performance gear and precision technologies and a segment of Vista Outdoor Inc. (NYSE: VSTO), today announced the appointment of Joe Beck as Chief Supply Chain Officer, effective April 22. In the third quarter, Revelyst launched GEAR Up, the company’s plan to simplify its business model, deliver increased efficiency and profitability, and reinvest in its highest potential brands to accele
AUSTIN, Texas, April 23, 2024--Jessica Long, one of the most decorated Paralympians and her Goldendoodle, Goose, join Nulo to champion its "Fuel Incredible" campaign.
BOSTON, April 23, 2024--hC Bioscience announces lead program in severe hemophilia A and shares preclinical data demonstrating proof-of-concept for tRNA-based protein editing.
SOUTH SAN FRANCISCO, Calif., April 23, 2024--Encoded Therapeutics Inc., a biotechnology company developing genetic medicines for severe central nervous system (CNS) disorders, today unveiled multiple pipeline programs ahead of the 27th ASGCT Annual meeting on May 7 - 11, 2024 in Baltimore, MD. Presentations will highlight progress of preclinical programs for Angelman syndrome, Lennox-Gastaut syndrome (LGS), STXBP1-related disorders (STXBP1-RD), Alzheimer’s disease (MAPT) and neuropathic pain (SC
Wnt-activated, autologous, expanded, adipose-derived stem cells administered directly into lateral ventricles of the brain via Ommaya reservoir implanted under the scalp to bypass blood brain barrierNEWPORT BEACH, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Regeneration Biomedical, Inc. (“RBI”), a clinical-stage company developing autologous stem cell treatments for neurodegenerative diseases, today announced that the first patient has been dosed in an FDA-cleared, first-in-human Phase 1 clinical
MILPITAS, Calif., April 23, 2024--Corsair Gaming, Inc. (Nasdaq: CRSR) ("Corsair" or the "Company"), a leading global provider and innovator of high-performance gear for gamers, streamers, content-creators, and gaming PC builders, today announced it will release its first quarter 2024 results and financial outlook after the Nasdaq close on Tuesday, May 7, 2024, with its management hosting a conference call to discuss results at 2:00 p.m. Pacific Time that same day.
ORLANDO, Fla., April 23, 2024--Laser Photonics Corporation (LPC) (NASDAQ: LASE), a leading global developer of industrial laser systems for cleaning and other material processing applications, announced today that it is attending this year's Offshore Technology Conference (OTC).
NEW YORK, April 23, 2024--The Arena Group announces the return of SURFER with a special print edition due out this summer. First published in 1960, this marks the revival of premium surf journalism, world-class photography, as well as a number of other exciting projects in the works.
NEW YORK, April 23, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced that the U.S. Food and Drug Administration (FDA) has allowed its intranasal foralumab non-active Secondary Progressive Multiple Sclerosis (na-SPMS) Expanded Access (EA) Program to expand from 10 patients to a total of 30 patients. To date, of the 10 partic
BALTIMORE, April 23, 2024--Sapio Sciences launches new multimodal registration capabilities for its unified laboratory informatics platform.
COLLIERVILLE, Tenn., April 23, 2024--Mueller Industries, Inc. (NYSE: MLI) announces results for the first quarter of 2024. Comparisons are to the first quarter of 2023.
–Phase 1 trial in collaboration with Sant Joan de Déu-Barcelona Children’s Hospital (SJD) determined to have a positive outcome by the study Monitoring Committee– –Safety and clinical outcomes support the therapeutic potential of VCN-01 in retinoblastoma and emphasize VCN-01’s potential for use in diverse cancer indications– ROCKVILLE, Md., April 23, 2024 (GLOBE NEWSWIRE) -- Theriva™ Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat c
Yahoo Finance